Articles by David Robinson
Dave Robinson mainly focuses his research on various aspects of corporate finance and financial reporting. He tracks how stock prices respond to new earning releases, for companies in a wide variety of sectors. Dave also enjoys looking for companies in currently unpopular industries, experiencing a short term setbacks in earnings, or spinoffs and asset sales, into newly created companies, and he aims to find these before they are discovered by the majority of other investors He received his MBA in Accounting and Finance from University of Houston.
Taro Pharmaceutical Industries Ltd (OTC:TAROF) has announced that they have begun the Phase 1 of clinical trials in Canada with T2007 which is second in the Company’s class of proprietary non-sedating barbiturate compounds to be …
Enzo Biochem Inc (NYSE:ENZ) has announced that they have signed an exclusive marketing deal with privately owned Ikonisys Inc of New Haven, CT.
Quidel Corporation (NASDAQ:QDEL) has announced that their Board of Directors have authorized for an extension of the Company’s current common stock repurchase program.
Depomed, Inc (NASDAQ:DEPO) announced that they have received a Paragraph IV certification notice from Lupin Limited advising Depomed of the filing of an Abbreviated New Drug Application (ANDA) with the Food and Drug Administration for …
NovaDel Pharma Inc. (AMEX:NVD) announced that they have received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715 entitled “Buccal, Polar and Non-Polar …
Pro-Pharmaceuticals, Inc. (OTC:PRWP) has announced that they have closed a US$310,000 tranche of a private placement for up to US$6.0 million with 10X Fund, L.P. which is purchasing their unregistered Series B convertible preferred stocks …
Depomed, Inc (NASDAQ:DEPO) today reported financial results for the third quarter that ended on September 30, 2009.
Whirlpool Corporation (NYSE:WHR) reported a higher than expected quarterly profit as cost cuts offset weak sales.
Honeywell International Inc. (NYSE:HON) announced that they have lowered their 2009 revenue guidance as they have reported a slide of 15 percent in their third quarter earnings.
OxiGENE and VaxGen on Thursday morning announced that they have entered into a definitive merger agreement where OxiGENE will acquire VaxGen in exchange for common stock of OxiGENE Inc.
